Disclaimer: Whilst we always aim to provide accurate information, Recite Me uses machine translation so the translation may not be perfect and we can’t guarantee its accuracy. Myeloma UK accepts no liability for any inaccuracies resulting from the use of this translation tool. The information provided is not meant to replace the advice of your healthcare team. Find out more about this tool at reciteme.com
This evidence-based module explores the pathophysiology of cancer and the principles of systemic anti-cancer therapy (SACT), while addressing the essential legal, ethical, and safety considerations involved. You will gain the expertise to manage common side effects of SACT and understand its impact on a patient’s physical, psychological, and social wellbeing.
Aligned with the RCN/UKONS/HEE (2022) Career Pathway and Education Framework, this module links theory with real-world outcomes, offering learners the opportunity to develop advanced practice in cancer care. However, practical clinical competence will require further assessment in accordance with local trust policies.
Ideal for those with at least six months’ experience in a SACT environment, this is your chance to deepen your impact in oncology through current research and evidence-based practice.
Course 1
Online live interactive sessions on: 5, 12, 21 November, 3 and 10 December 2024 Submission date: 28 January 2025
Course 2
Online live interactive sessions on: 25 February, 4, 11, 18 and 25 March 2025 Submission date: 20 May 2025
Course 3
Online live interactive sessions on: 3, 10, 17, 24 June and 1 July 2025 Submission date: 27 August 2025
–
